AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22093142 — intervention group
Group type: COMPARATOR
Intervention: Routine care (RC)
Number of subjects: 183
Study 22093142 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive multifactorial treatment (IT)
Number of subjects: 183
Study 20556536 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephonic disease management program
Number of subjects: 295
Study 20556536 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 295
Study 17534233 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged intra-aortic balloon pumping (IABP) for additional seven days
Number of subjects: 39
Study 17534233 — intervention group
Group type: COMPARATOR
Intervention: Control group ceased IABP
Number of subjects: 39
Study 15656848 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation breathing exercise combined with physical exercise for 30 minutes daily for six weeks
Number of subjects: 35
Study 15656848 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 35
Study 12173197 — intervention group
Group type: EXPERIMENTAL
Intervention: sufentanil 50 micrograms via a lumbar epidural catheter before surgery
Number of subjects: 41
Study 10456815 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (50, 100, and 200 ng x mL(‐1))
Number of subjects: 8
Study 10456815 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil (50 ng x mL(‐1))
Number of subjects: 8
Study 10456815 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 8
Study 8554633 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 Hz magnetic field (1.1 mT, 5 min exposure)
Number of subjects: 36
Study 8554633 — intervention group
Group type: COMPARATOR
Intervention: 0.1 Hz magnetic field (1.1 mT, 5 min exposure)
Number of subjects: 36
Study 8554633 — intervention group
Group type: COMPARATOR
Intervention: Sham field (control)
Number of subjects: 36
Study 8554633 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 Hz magnetic field in second study
Number of subjects: 36
Study 2164559 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct electron microscopy (EM)
Number of subjects: 1
Study 2164559 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of parvovirus
Number of subjects: 1
Study 2164559 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis of opportunistic viral infections
Number of subjects: 1
Study 858795 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual treatment depicting a dyadic psychotherapy situation with varying therapist age and status.
Number of subjects: 60
Study 31131818 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemorrhoidal arteries ligation under pudendal nerve block
Number of subjects: 0
Study 31131818 — intervention group
Group type: COMPARATOR
Intervention: Doppler guided hemorrhoidal arteries ligation under spinal anaesthesia
Number of subjects: 0
Study 28718236 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin Immediate Release (MIR) 1000 mg twice daily
Number of subjects: 90
Study 28718236 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin Extended Release (MXR) 1000 mg twice daily
Number of subjects: 90
Study 28718236 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin Extended Release (MXR) 500 mg twice daily
Number of subjects: 90
Study 25371036 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual maximum bladder capacity (MBC)
Number of subjects: 1840
Study 25371036 — intervention group
Group type: COMPARATOR
Intervention: Fixed bladder volume of 500 ml
Number of subjects: 1840
Study 23573880 — intervention group
Group type: EXPERIMENTAL
Intervention: Bidirectional knotless barbed suture (0-Quill™; Angiotech Pharmaceuticals, Inc.)
Number of subjects: 61
Study 23573880 — intervention group
Group type: COMPARATOR
Intervention: Standard sutures with either extracorporeal or intracorporeal knots (1-Monocryl®; Ethicon Inc.)
Number of subjects: 61
Study 21771179 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 0
Study 21771179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19691748 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% topical minoxidil
Number of subjects: 300
Study 19691748 — intervention group
Group type: COMPARATOR
Intervention: 1% topical minoxidil
Number of subjects: 300
Study 17301299 — intervention group
Group type: EXPERIMENTAL
Intervention: Live attenuated influenza vaccine
Number of subjects: 8352
Study 17301299 — intervention group
Group type: COMPARATOR
Intervention: Inactivated vaccine
Number of subjects: 8352
Study 14752074 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention (n = 118)
Number of subjects: 237
Study 14752074 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (n = 119)
Number of subjects: 237
Study 11693063 — intervention group
Group type: EXPERIMENTAL
Intervention: Idarubicine
Number of subjects: 60
Study 11693063 — intervention group
Group type: COMPARATOR
Intervention: Mitoxantrone
Number of subjects: 60
Study 7939401 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy follow-up for polyps < 10 mm
Number of subjects: 116
Study 2905709 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 7
Study 2905709 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 7
Study 2905709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 29437307 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face instruction with no audiovisual support
Number of subjects: 2225
Study 29437307 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face instruction with audiovisual support
Number of subjects: 2225
Study 29437307 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual instruction without face-to-face instruction
Number of subjects: 2225
Study 29437307 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual instruction with face-to-face instruction
Number of subjects: 2225
Study 29437307 — intervention group
Group type: COMPARATOR
Intervention: Control group (no instruction)
Number of subjects: 2225
Study 27908464 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 weeks of exercise rehabilitation
Number of subjects: 42
Study 27908464 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 weeks of exercise rehabilitation
Number of subjects: 42
Study 29378102 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard diet plus two jelly drinks a day for 2 weeks
Number of subjects: 50
Study 29378102 — intervention group
Group type: COMPARATOR
Intervention: Standard diet (Control group)
Number of subjects: 50
Study 24163238 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone text-messaging intervention for 12 weeks
Number of subjects: 179
Study 24163238 — intervention group
Group type: COMPARATOR
Intervention: Self-help pamphlet about smoking cessation
Number of subjects: 179
Study 20538982 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord serum
Number of subjects: 32
Study 20538982 — intervention group
Group type: COMPARATOR
Intervention: Autologous serum
Number of subjects: 32
Study 20538982 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears (0.5% HPMC+0.3% glycerin)
Number of subjects: 32
Study 20538982 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears
Number of subjects: 32
Study 18215977 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) plus stavudine and lamivudine
Number of subjects: 0
Study 18215977 — intervention group
Group type: EXPERIMENTAL
Intervention: Switching from stavudine to tenofovir
Number of subjects: 0
Study 18215977 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) therapy
Number of subjects: 0
Study 16704091 — intervention group
Group type: EXPERIMENTAL
Intervention: Straight wire appliance
Number of subjects: 80
Study 16704091 — intervention group
Group type: COMPARATOR
Intervention: Edgewise appliance
Number of subjects: 80
Study 14669176 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic total contact seat
Number of subjects: 207
Study 14669176 — intervention group
Group type: COMPARATOR
Intervention: Low air loss bed
Number of subjects: 207
Study 14669176 — intervention group
Group type: COMPARATOR
Intervention: Upgraded bed overlay
Number of subjects: 207
Study 10892659 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (50 mg/day for 3 days)
Number of subjects: 9
Study 10892659 — intervention group
Group type: EXPERIMENTAL
Intervention: Coadministration of Ang II (0.3 ng/min)
Number of subjects: 9
Study 10892659 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan pretreatment with Ang II
Number of subjects: 9
Study 10892659 — intervention group
Group type: COMPARATOR
Intervention: Control (no losartan)
Number of subjects: 9
Study 10892659 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 9
Study 8814373 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron (single intravenous dose)
Number of subjects: 26
Study 8814373 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron (twice-daily oral for 3 or 4 days)
Number of subjects: 26
Study 8814373 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 26
Study 8814373 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron
Number of subjects: 26
Study 1300214 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of covariance (ANCOVA) for baseline correction
Number of subjects: 0
Study 1300214 — intervention group
Group type: COMPARATOR
Intervention: Simple pre‐post difference scores and percentage change scores
Number of subjects: 0
Study 3918652 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound treatment
Number of subjects: 76
Study 3918652 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 31003626 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with extra-virgin olive oil (n=2543)
Number of subjects: 7447
Study 31003626 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with nuts (n=2454)
Number of subjects: 7447
Study 31003626 — intervention group
Group type: COMPARATOR
Intervention: Control diet (advice to reduce dietary fat; n=2450)
Number of subjects: 7447
Study 29372023 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic lumbar facet joint nerve blocks
Number of subjects: 0
Study 29372023 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost of therapeutic lumbar facet joint nerve blocks
Number of subjects: 0
Study 26784272 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (35,000 IU/week)
Number of subjects: 65
Study 26784272 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 24681179 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg parecoxib injection 30‐45 min before anesthesia induction and 4 ml saline injection when gallbladder was removed
Number of subjects: 120
Study 24681179 — intervention group
Group type: COMPARATOR
Intervention: 4 ml saline injection 30‐45 min before anesthesia induction and 40 mg parecoxib injection when gallbladder was removed
Number of subjects: 120
Study 24681179 — intervention group
Group type: COMPARATOR
Intervention: 4 ml saline injection 30‐45 min before anesthesia induction and the time when gallbladder was removed
Number of subjects: 120
Study 22063735 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone treatment within the first week after onset of symptoms
Number of subjects: 2
Study 22063735 — intervention group
Group type: COMPARATOR
Intervention: No medication (control group)
Number of subjects: 2
Study 19348542 — intervention group
Group type: EXPERIMENTAL
Intervention: Blushing
Number of subjects: 128
Study 19348542 — intervention group
Group type: COMPARATOR
Intervention: Neutral expression without blushing
Number of subjects: 128
Study 17636090 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecopipam 100 mg daily for 12 weeks
Number of subjects: 1667
Study 17636090 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecopipam 100 mg daily for 52 weeks
Number of subjects: 1667
Study 17636090 — intervention group
Group type: COMPARATOR
Intervention: Ecopipam vs. placebo
Number of subjects: 1667
Study 17636090 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecopipam
Number of subjects: 1667
Study 15691239 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled hypertonic saline (4.5% for ≤ 15 min without bronchodilator pretreatment)
Number of subjects: 56
Study 15691239 — intervention group
Group type: COMPARATOR
Intervention: Inhaled methacholine (maximum cumulative dose 4 micromol)
Number of subjects: 56
Study 12674492 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive home visits in intervention communities
Number of subjects: 4059
Study 12674492 — intervention group
Group type: COMPARATOR
Intervention: Control communities (no intervention)
Number of subjects: 4059
Study 10037073 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (100 to 250 microg) given daily until neutrophil counts rose to greater than 1000/microL
Number of subjects: 24
Study 10037073 — intervention group
Group type: COMPARATOR
Intervention: Untreated group receiving antibiotic therapy only
Number of subjects: 24
Study 7793470 — intervention group
Group type: EXPERIMENTAL
Intervention: ECT with right unilateral electrode placement and low intensity stimulus
Number of subjects: 71
Study 7793470 — intervention group
Group type: EXPERIMENTAL
Intervention: ECT with right unilateral electrode placement and high intensity stimulus
Number of subjects: 71
Study 7793470 — intervention group
Group type: EXPERIMENTAL
Intervention: ECT with bilateral electrode placement and low intensity stimulus
Number of subjects: 71
Study 7793470 — intervention group
Group type: EXPERIMENTAL
Intervention: ECT with bilateral electrode placement and high intensity stimulus
Number of subjects: 71
Study 2033693 — intervention group
Group type: EXPERIMENTAL
Intervention: Thromboembolic stockings
Number of subjects: 74
Study 2033693 — intervention group
Group type: EXPERIMENTAL
Intervention: External sequential pneumatic compression stockings
Number of subjects: 74
Study 2033693 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin plus dihydroergotamine
Number of subjects: 74
Study 6763394 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dose tobramycin
Number of subjects: 29
Study 6763394 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose tobramycin
Number of subjects: 29
Study 6763394 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dose amikacin
Number of subjects: 29
Study 6763394 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose amikacin
Number of subjects: 29
Study 30460609 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 20,000 IU/week for 12 weeks
Number of subjects: 100
Study 30460609 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 29208620 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical decision support tool
Number of subjects: 0
Study 29208620 — intervention group
Group type: COMPARATOR
Intervention: Passive access to institutional guidelines
Number of subjects: 0
Study 26322834 — intervention group
Group type: EXPERIMENTAL
Intervention: Microaneurysm activity using the RetmarkerDR
Number of subjects: 374
Study 26322834 — intervention group
Group type: EXPERIMENTAL
Intervention: Microaneurysm turnover
Number of subjects: 374
Study 26322834 — intervention group
Group type: EXPERIMENTAL
Intervention: ETDRS severity level assessment
Number of subjects: 374
Study 26322834 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectral-domain optical coherence tomography (SD-OCT)
Number of subjects: 374
Study 26322834 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinal thickness assessment
Number of subjects: 374
Study 25715720 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid maxillary expansion (RME) using Haas expander
Number of subjects: 30
Study 25715720 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated individuals)
Number of subjects: 30
Study 22772870 — intervention group
Group type: EXPERIMENTAL
Intervention: S-pantoprazole 20 mg
Number of subjects: 129
Study 22772870 — intervention group
Group type: COMPARATOR
Intervention: pantoprazole 40 mg
Number of subjects: 129
Study 19773005 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based West Nile virus health education program
Number of subjects: 345
Study 17323787 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg (pretreatment)
Number of subjects: 148
Study 17323787 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg (concomitant treatment)
Number of subjects: 148
Study 17323787 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 17323787 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (both treatments)
Number of subjects: 148
Study 15712732 — intervention group
Group type: EXPERIMENTAL
Intervention: Lomb-Scargle periodogram (LSP)
Number of subjects: 0
Study 15712732 — intervention group
Group type: COMPARATOR
Intervention: Fast Fourier Transform (FFT)
Number of subjects: 0
Study 15712732 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep stage segmentation
Number of subjects: 0
Study 11424301 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard random effects model
Number of subjects: 0
Study 11424301 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified test
Number of subjects: 0
Study 9844097 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical jumping exercise (50 jumps, 6 days/week, mean height 8.5 cm)
Number of subjects: 123
Study 9844097 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 123
Study 9844097 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical jumping exercise (50 jumps, 6 days/week)
Number of subjects: 123
Study 7857732 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 298
Study 7857732 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 298
Study 2754630 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline treatment for seven weeks with plasma levels kept between 50‐180 ng/ml
Number of subjects: 31
Study 2754630 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline treatment
Number of subjects: 31
Study 865738 — intervention group
Group type: EXPERIMENTAL
Intervention: Analgesia
Number of subjects: 115
Study 865738 — intervention group
Group type: COMPARATOR
Intervention: General inhalation anesthesia
Number of subjects: 115
Study 865738 — intervention group
Group type: EXPERIMENTAL
Intervention: Analgesia and General inhalation anesthesia
Number of subjects: 115
Study 31125086 — intervention group
Group type: EXPERIMENTAL
Intervention: Diverse window views and different daylight exposure in 46 different patient rooms
Number of subjects: 296
Study 27416930 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher proportion of photos of mothers interacting with their babies
Number of subjects: 20
Study 27416930 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower proportion of posts of baby smiling photos
Number of subjects: 20
Study 25755148 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based walking exercise program with training, monitoring and coaching (TMC) components over 14 weeks
Number of subjects: 25
Study 25755148 — intervention group
Group type: COMPARATOR
Intervention: Standard advice to walk (control group)
Number of subjects: 25
Study 23815562 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan/Amlodipine combination (20/5 mg)
Number of subjects: 276
Study 23815562 — intervention group
Group type: COMPARATOR
Intervention: Olmesartan (20 mg)
Number of subjects: 276
Study 23815562 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine (10 mg)
Number of subjects: 276
Study 21883159 — intervention group
Group type: EXPERIMENTAL
Intervention: Secure attachment with moderately irritable infants
Number of subjects: 84
Study 21883159 — intervention group
Group type: EXPERIMENTAL
Intervention: Secure attachment with highly irritable infants
Number of subjects: 84
Study 21883159 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecure attachment with moderately irritable infants
Number of subjects: 84
Study 21883159 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecure attachment with highly irritable infants
Number of subjects: 84
Study 21883159 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly irritable and insecurely attached toddlers
Number of subjects: 84
Study 21883159 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately irritable and insecurely attached toddlers
Number of subjects: 84
Study 19218075 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft tissue release (STR)
Number of subjects: 20
Study 19218075 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 20
Study 17374567 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored individualized feedback based on the Transtheoretical Model of Behavior Change using a computer‐based multimedia program
Number of subjects: 0
Study 17374567 — intervention group
Group type: COMPARATOR
Intervention: General information on contraception
Number of subjects: 0
Study 12718225 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethazidine (20 mg thrice a day)
Number of subjects: 20
Study 12718225 — intervention group
Group type: COMPARATOR
Intervention: Standard basic therapy
Number of subjects: 20
Study 11206600 — intervention group
Group type: COMPARATOR
Intervention: sertraline, 50 mg/day
Number of subjects: 44
Study 11206600 — intervention group
Group type: EXPERIMENTAL
Intervention: sertraline, 100 mg/day
Number of subjects: 44
Study 11206600 — intervention group
Group type: EXPERIMENTAL
Intervention: fluoxetine, 20 mg/day
Number of subjects: 44
Study 11206600 — intervention group
Group type: EXPERIMENTAL
Intervention: sertraline, 100 mg/day (after dose increase)
Number of subjects: 44
Study 11206600 — intervention group
Group type: EXPERIMENTAL
Intervention: sertraline, 200 mg/day (after dose increase)
Number of subjects: 44
Study 11206600 — intervention group
Group type: EXPERIMENTAL
Intervention: fluoxetine, 40 mg/day (after dose increase)
Number of subjects: 44
Study 9313279 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo cream with suggestion that it might help reduce needle pain
Number of subjects: 117
Study 9313279 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo cream with no indication of purpose
Number of subjects: 117
Study 9313279 — intervention group
Group type: COMPARATOR
Intervention: No cream (control group)
Number of subjects: 117
Study 9313279 — intervention group
Group type: EXPERIMENTAL
Intervention: Observer ratings for cream plus suggestion
Number of subjects: 117